Skip to content

Abbott ABT Unrecognized compensation cost related to non-vested awards

Unrecognized compensation cost related to non-vested awards at other companies

Edwards Lifesciences logo
Edwards LifesciencesEW

Other financials

Income statement

See full
Revenue$11.2B+7.8%
Gross profit$6.3B+6.5%
Operating income$1.3B-20.6%
Net income$1.1B-18.7%
EPS (diluted)$0.61-19.7%

Balance sheet

See full
Cash & equivalents$6.8B+4.2%
Total debt$34.0B+157%
Total equity$52.1B+6.7%
Total assets$110.43B+35.6%

Cash flow

See full
Operating cash flow$1.3B-7.2%
CapEx$399.0M-17.6%
Free cash flow$916.0M-1.8%

Valuation

See full
Market cap$154.15B-22.5%
Enterprise value$181.39B-13.1%
P/E24.6×+9.8×
P/S3.4×-1.3×

Profitability

See full
Gross margin56.3%+0.4pp
Operating margin17.1%+0.2pp
Net margin13.9%-18.0pp

Returns & leverage

See full
Return on equity12.4%-18.4pp
Debt / equity0.7×+0.4×
Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.

The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Abbott's unrecognized compensation cost related to non-vested awards.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Abbott's unrecognized compensation cost related to non-vested awards?
Abbott (ABT) reported unrecognized compensation cost related to non-vested awards of $914M in Q1 2026.
How has Abbott's unrecognized compensation cost related to non-vested awards changed year-over-year?
Abbott's unrecognized compensation cost related to non-vested awards increased by 15.7% year-over-year, from $790M to $914M.
What is the long-term trend for Abbott's unrecognized compensation cost related to non-vested awards?
Over 3 years (2022 to 2025), Abbott's unrecognized compensation cost related to non-vested awards has grown at a -1.9% compound annual growth rate (CAGR), from $494M to $467M.